1. Home
  2. ELUT vs PRPO Comparison

ELUT vs PRPO Comparison

Compare ELUT & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.07

Market Cap

50.8M

Sector

Health Care

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$26.16

Market Cap

44.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
PRPO
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
50.8M
44.4M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
ELUT
PRPO
Price
$1.07
$26.16
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
172.6K
8.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.14
35.03
EPS
N/A
N/A
Revenue
$24,375,000.00
$18,532,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.95
52 Week Low
$0.50
$4.90
52 Week High
$3.46
$28.50

Technical Indicators

Market Signals
Indicator
ELUT
PRPO
Relative Strength Index (RSI) 53.01 61.56
Support Level $0.86 $22.58
Resistance Level $1.15 $28.38
Average True Range (ATR) 0.14 1.47
MACD -0.01 0.39
Stochastic Oscillator 13.24 91.14

Price Performance

Historical Comparison
ELUT
PRPO

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: